Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines
The Long Run with Luke Timmerman
00:00
Multiple routes and oral opportunities
Ron outlines Hungry's portfolio: injectable dual agonist, oral peptide, oral small molecule, and a triple agonist.
Play episode from 19:26
Transcript
